Angiotensin-converting enzyme and apolipoproteins genes polymorphism in coronary artery disease

Clinical Cardiology

Volumn 23, Issue 5, 2000, Pages 335-340

  De Padua Mansur, Antonio ^a   Annicchino Bizzacchi, Joyce ^b   Favarato, Desidério ^a   Avakian, Solange D ^a   César, Luíz A M ^a   Ramires, José A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Angiotensin converting enzyme; Apolipoprotein AI; Apolipoprotein B; Apolipoprotein E; Coronary artery disease; Gene polymorphism; Genetics

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0343963720     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230506     Document Type: Article

References (35)

1. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ: Genetic-epidemiologic study of early onset ischaemic heart disease. Circulation 1980;61:503-508
2. Hoit BD, Gilpin EA, Henning H, Maisel AA, Dittrich H, Carlisle J, Ross J Jr: Myocardial infarction in young patients: An analysis by age subsets. Circulation 1986;74:712-721
3. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U: Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-1046
4. Marian AJ: Genetic markers: Genes involved in human hypertension. J Cardiovasc Risk 1997;4:341 -345
5. Lusis AJ: Genetic factors affecting blood lipoproteins: The candidate gene approach. J Lipid Res 1988;29:397-429
6. Samani NJ, O'Toole L, Channer K, Woods KL: A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94: 708-712
7. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM: Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255
8. Freidewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
9. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239: 487-491
10. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711
11. Pagani F, Sidoli A, Giudici, GA, Vergani C, Baralle EE: Association of a polymorphism in the apo AI gene promoter with hyperalphalipoproteinemia. In: Biotechnology of Dyslipoproteinemias: Applications in Diagnosis and Control (Eds. Lenfant C, Paoletti R, Catapano AL, Albertini A). New York, NY: Raven Press, 1990
12. Pajukanta PE, Valsta LM, Aro A, Pietinen P, Heliö T, Tikkanen MJ: The effects of the apolipoprotein B signal peptide (ins/del) and Xbal polymorphisms on plasma lipid responses to dietary change. Atherosclerosis 1993;122:1-10
13. Zevelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U: Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 1997;43:1657-1659
14. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-643
15. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711
16. Régis-Bailly A, Fournier B, Steinmetz J, Gueguen R, Siest G, Visvikis S: Apo B signal peptide insertion/deletion polymorphism is involved in postprandial lipoparticles' responses. Atherosclerosis 1995;118:23-34
17. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F, Jimenez-Pereperez J, Perez-Gimenez F: Influence of mutation in human apolipoprotein A-I promoter on plasma LDL cholesterol response to dietary fat. Lancet 1994;343:1246-1249
18. McCarthy BJ: Polymorphisms and markers associated with apolipoprotein B. Curr Opin Lipidol 1991;2:81-85
19. Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL: Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 1986; 315:1509-1515
20. Peacock R, Dunning A, Hamsten A, Tornvall P, Humphies S, Talmud P: Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 1992;92:151-164
21. Calabresi L, Franceschini G: High density lipoprotein and coronary heart disease: Insights from mutations leading to low high density lipoprotein. Curr Opin Lipidol 1997;8:219-224
22. Lehtinen S, Lehtimäki T, Sisto T, Salenius J-P, Nikkilä M, Jokela H, Koivula T, Ebeling F, Ehnholm C: Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 1995;114:83-91
23. Damaraju S, Yu QT, Safavi F, Marian AJ: Apolipoprotein E4 is not a risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;75: 1181-1183
24. Reilly SL, Ferrel RE, Sing CF: The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minn. III: Correlations and covariances. Am J Hum Genet 1994;55:1001-1018
25. Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer DM, Allen A, Karagounis LA, Ward RH: Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation 1994;89:567-577
26. Humphies SE: DNA polymorphisms of the apolipoprotein genes -their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis 1988;72:89-108
27. Smith JD, Brinton EA, Breslow JL: Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter in vitro. J Clin Invest 1992;89:1796-1800
28. Angotti E, Mele E, Costanzo F, Avvedimento EV: A polymorphism (G→A transition) in the - 78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 1994;269: 17371-17374
29. Danek GM, Valenti M, Baralle FE, Romano M: The A/G polymorphism in the - 78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency. Biochim Biophys Acta 1998;1398:67-74
30. Wang XL, Liu SX, McCredie, Wilcken DEL: Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 1996;98:372-377
31. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21
32. Luc G, Bard J, Arveiler D, Evans A, Cambou J, Bingham A, Amouyel P, Schaffer P, Ruidavets J, Cambien F, Fruchart J, Ducimetiere P: Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: The ECTIM Study. ArteriosclerThromb 1994;14:1412-1419
33. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: The Framingham Offspring Study. J Am Med Assoc 1994;272:1666-1671
34. Laan M, Paabo S: Demographic history and linkage disequilibrium in human populations. Nat Genet 1997;17:435-438
35. McKeigue PM: Mapping genes underlying ethnic differences in disease risk by linkage disequilibrium in recently admixed populations. Am J Hum Genet 1997;60:188-196